Author

Collin T. Stabler

University of PennsylvaniaORCID 0000-0002-5458-8239Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Aparajeeta MajumderiD· 1 shared Edward E. MorriseyiD· 1 shared Jacob Samuel BrenneriD· 1 shared Jacob W. MyersoniD· 1 shared Jia NongiD· 1 shared Jichuan WuiD· 1 shared Laura Ferguson· 1 shared Liam S. ChaseiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Aparajeeta MajumderORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Nanoparticle Albumin-Bound Paclitaxel Targets Pulmonary Neutrophils

Aparajeeta Majumder, Soomin Jeong, Marco Zamora, Nicolas Marzolini, Yufei Wang, Jia Nong, Taylor V. Brysgel, Priyal Patel, Michael H. Zaleski, Jichuan Wu, Collin T. Stabler, Liam S. Chase, Zhicheng Wang, Edward E. Morrisey, Vladimir Muzykantov, , Jacob W. Myerson

This paper identifies pulmonary neutrophils as the primary target of Abraxane in lung cancer and shows that its efficacy depends on complement pathway-mediated lung uptake.

bioRxiv · Sep 28, 2026 · PreprintBioengineering